Burden and challenges of heart failure in patients with chronic kidney disease. A call to action

Bello, 2017, Complications of chronic kidney disease: current state, knowledge gaps, and strategy for action, Kidney Int Suppl, 7, 122, 10.1016/j.kisu.2017.07.007 Levin, 2017, Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policy, Lancet, 390, 1888, 10.1016/S0140-6736(17)30788-2 Herzog, 2011, Cardiovascular disease in chronic kidney disease. A clinical update from Kidney Disease: Improving Global Outcomes (KDIGO), Kidney Int, 80, 572, 10.1038/ki.2011.223 House, 2019, Heart failure in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference, Kidney Int, 95, 1304, 10.1016/j.kint.2019.02.022 Keith, 2004, Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization, Arch Intern Med, 164, 659, 10.1001/archinte.164.6.659 McAlister, 2012, Renal dysfunction in patients with heart failure with preserved versus reduced ejection fraction: impact of the new Chronic Kidney Disease-Epidemiology Collaboration Group formula, Circ Heart Fail, 5, 309, 10.1161/CIRCHEARTFAILURE.111.966242 Heywood, 2007, High prevalence of renal dysfunction and its impact on outcome in 118,465 patients hospitalized with acute decompensated heart failure: a report from the ADHERE database, J Card Fail, 13, 422, 10.1016/j.cardfail.2007.03.011 United States Renal Data System. Annual Data Report 2016: Chapter 9: Cardiovascular disease in patients with ESRD. Available at: https://www.usrds.org/2016/view/v2_09.aspx?zoom_highlight=dialysis+heart+failure [accessed 7.04.19]. Wu, 2005, Comorbid conditions in kidney transplantation: association with graft and patient survival, J Am Soc Nephrol, 16, 3437, 10.1681/ASN.2005040439 Lentine, 2005, De novo congestive heart failure after kidney transplantation: a common condition with poor prognostic implications, Am J Kidney Dis, 46, 720, 10.1053/j.ajkd.2005.06.019 Siedlecki, 2007, The impact of left ventricular systolic dysfunction on survival after renal transplantation, Transplantation, 84, 1610, 10.1097/01.tp.0000295748.42884.97 Wali, 2005, Effect of kidney transplantation on left ventricular systolic dysfunction and congestive heart failure in patients with end-stage renal disease, J Am Coll Cardiol, 45, 1051, 10.1016/j.jacc.2004.11.061 Savarese, 2017, Global public health burden of heart failure, Card Fail Rev, 3, 7, 10.15420/cfr.2016:25:2 Kottgen, 2007, Reduced kidney function as a risk factor for incident heart failure: the Atherosclerosis Risk in Communities (ARIC) study, J Am Soc Nephrol, 18, 1307, 10.1681/ASN.2006101159 Bansal, 2017, Absolute rates of heart failure, coronary heart disease, and stroke in chronic kidney disease: an analysis of 3 community-based cohort studies, JAMA Cardiol, 2, 314, 10.1001/jamacardio.2016.4652 Rigatto, 2002, Congestive heart failure in renal transplant recipients: risk factors, outcomes, and relationship with ischemic heart disease, J Am Soc Nephrol, 13, 1084, 10.1681/ASN.V1341084 Lofman, 2017, Associations with and prognostic impact of chronic kidney disease in heart failure with preserved, mid-range, and reduced ejection fraction, Eur J Heart Fail, 19, 1606, 10.1002/ejhf.821 Faravardeh, 2013, Predictors of graft failure and death in elderly kidney transplant recipients, Transplantation, 96, 1089, 10.1097/TP.0b013e3182a688e5 Mathur, 2017, Patterns of care and outcomes in cardiovascular disease after kidney transplantation in the United States, Transplant Direct, 3, e126, 10.1097/TXD.0000000000000640 United States Renal Data System. Annual Data Report 2016: Chapter 6: Medicare expenditures for persons with CKD. Available at: https://www.usrds.org/2016/view/v2_09.aspx?zoom_highlight=dialysis+heart+failure [accessed 7.04.19]. Sicras Mainar, 2016, Impacto económico de la insuficiencia cardiaca según la influencia de la insuficiencia renal, Rev Esp Cardiol, 68, 39, 10.1016/j.recesp.2014.02.023 Tumlin, 2013, Cardiorenal syndrome type 4: insights on clinical presentation and pathophysiology from the eleventh consensus conference of the Acute Dialysis Quality Initiative (ADQI), Contrib Nephrol, 182, 158, 10.1159/000349972 Rangaswami, 2018, Heart failure in end-stage kidney disease: pathophysiology, diagnosis, and therapeutic strategies, Semin Nephrol, 38, 600, 10.1016/j.semnephrol.2018.08.005 Wang, 2019, Evolving concepts in the pathogenesis of uraemic cardiomyopathy, Nat Rev Nephrol, 15, 159, 10.1038/s41581-018-0101-8 López, 2008, Myocardial fibrosis in chronic kidney disease: potential benefits of torasemide, Kidney Int, 74, S19, 10.1038/ki.2008.512 Zannad, 2018, Cardiorenal syndrome revisited, Circulation, 138, 929, 10.1161/CIRCULATIONAHA.117.028814 Brower, 2006, The relationship between myocardial extracellular matrix remodeling and ventricular function, Eur J Cardiothorac Surg, 30, 604, 10.1016/j.ejcts.2006.07.006 García-Fernández, 2019, Increased fibroblast growth factor 23 in heart failure: biomarker, mechanism, or both?, Am J Hypertens, 32, 15, 10.1093/ajh/hpy153 Takahama, 2017, Pathophysiology of cardiorenal syndrome in patients with heart failure: potential therapeutic targets, Am J Physiol Heart Circ Physiol, 313, H715, 10.1152/ajpheart.00215.2017 López, 2014, Association of cardiotrophin-1 with myocardial fibrosis in hypertensive patients with heart failure, Hypertension, 63, 483, 10.1161/HYPERTENSIONAHA.113.02654 López, 2009, Association of plasma cardiotrophin-1 with stage C heart failure in hypertensive patients: potential diagnostic implications, J Hypertens, 27, 418, 10.1097/HJH.0b013e32831ac981 López-Andrés, 2012, Cardiotrophin 1 is involved in cardiac, vascular, and renal fibrosis and dysfunction, Hypertension, 60, 563, 10.1161/HYPERTENSIONAHA.112.194407 Martínez-Martínez, 2019, CT-1 (Cardiotrophin-1)-Gal-3 (Galectin-3) axis in cardiac fibrosis and inflammation, Hypertension, 73, 602, 10.1161/HYPERTENSIONAHA.118.11874 Palazzuoli, 2016, Chronic kidney disease and worsening renal function in acute heart failure: different phenotypes with similar prognostic impact?, Eur Heart J Acute Cardiovasc Care, 5, 534, 10.1177/2048872615589511 Mentz, 2016, Pathophysiology and clinical evaluation of acute heart failure, Nat Rev Cardiol, 13, 28, 10.1038/nrcardio.2015.134 Ponikowski, 2016, Eur Heart J, 37, 2129, 10.1093/eurheartj/ehw128 Chawla, 2014, Proposal for a functional classification system of heart failure in patients with end-stage renal disease: proceedings of the acute dialysis quality initiative (ADQI) XI workgroup, J Am Coll Cardiol, 63, 1246, 10.1016/j.jacc.2014.01.020 Arrigo, 2018, Soluble CD146 and B-type natriuretic peptide dissect overhydration into functional components of prognostic relevance in haemodialysis patients, Nephrol Dial Transplant, 33, 2035, 10.1093/ndt/gfy113 Untersteller, 2018, Validation of echocardiographic criteria for the clinical diagnosis of heart failure in chronic kidney disease, Nephrol Dial Transplant, 33, 653, 10.1093/ndt/gfx197 Maisel, 2008, State of the art: using natriuretic peptide levels in clinical practice, Eur J Heart Fail, 10, 824, 10.1016/j.ejheart.2008.07.014 van Kimmenade, 2009, Renal clearance of B-type natriuretic peptide and amino terminal pro-B-type natriuretic peptide, J Am Coll Cardiol, 53, 884, 10.1016/j.jacc.2008.11.032 Vodovar, 2015, Elevated plasma B-type natriuretic peptide concentrations directly inhibit circulating neprilysin activity in heart failure, JACC: Heart Fail, 3, 629 Emrich, 2019, Do plasma neprilysin activity and plasma neprilysin concentration predict cardiac events in chronic kidney disease patients?, Nephrol Dial Transplant, 34, 100, 10.1093/ndt/gfy066 Mueller, 2019, Heart Failure Association of the European Society of Cardiology practical guidance on the use of natriuretic peptide concentrations, Eur J Heart Fail, 21, 715, 10.1002/ejhf.1494 He, 2017, Risk factors for heart failure in patients with chronic kidney disease: the CRIC (Chronic Renal Insufficiency Cohort) study, J Am Heart Assoc, 6 Upadhya, 2017, Effect of intensive blood pressure treatment on heart failure events in the systolic blood pressure reduction intervention trial, Circ Heart Fail, 10, e003613, 10.1161/CIRCHEARTFAILURE.116.003613 Rahman, 2012, Long-term renal and cardiovascular outcomes in Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) participants by baseline estimated GFR, Clin J Am Soc Nephrol, 7, 989, 10.2215/CJN.07800811 Brenner, 2001, Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy, N Engl J Med, 345, 861, 10.1056/NEJMoa011161 Zelniker, 2019, SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials, Lancet, 393, 31, 10.1016/S0140-6736(18)32590-X Zinman, 2015, Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes, N Engl J Med, 373, 2117, 10.1056/NEJMoa1504720 Wanner, 2018, Empagliflozin and clinical outcomes in patients with type 2 diabetes mellitus, established cardiovascular disease, and chronic kidney disease, Circulation, 137, 119, 10.1161/CIRCULATIONAHA.117.028268 Neal, 2017, Canagliflozin and cardiovascular and renal events in type 2 diabetes, N Engl J Med, 377, 644, 10.1056/NEJMoa1611925 Perkovic, 2019, Canagliflozin and renal outcomes in type 2 diabetes and nephropathy, N Engl J Med, 380, 2295, 10.1056/NEJMoa1811744 Wiviott, 2019, Dapagliflozin and cardiovascular outcomes in type 2 diabetes, N Engl J Med, 380, 347, 10.1056/NEJMoa1812389 Charytan, 2006, The exclusion of patients with chronic kidney disease from clinical trials in coronary artery disease, Kidney Int, 70, 2021, 10.1038/sj.ki.5001934 Coca, 2006, Under representation of renal disease in randomized controlled trials of cardio-vascular disease, JAMA, 296, 1377, 10.1001/jama.296.11.1377 Konstantinidis, 2016, Representation of patients with kidney disease in trials of cardiovascular interventions: an updated systematic review, JAMA Intern Med, 176, 121, 10.1001/jamainternmed.2015.6102 Zannad, 2017, Cardiovascular outcome trials in patients with advanced kidney disease: time for action, Circulation, 135, 1769, 10.1161/CIRCULATIONAHA.117.027338 Hein, 2019, Medical management of heart failure with reduced ejection fraction in patients with advanced renal disease, JACC Heart Fail, 7, 371, 10.1016/j.jchf.2019.02.009 Damman, 2014, Current evidence on treatment of patients with chronic systolic heart failure and renal insufficiency: practical considerations from published data, J Am Coll Cardiol, 63, 853, 10.1016/j.jacc.2013.11.031 Afsar, 2017, Heart failure with preserved ejection fraction: a nephrologist-directed primer, Heart Fail Rev, 22, 765, 10.1007/s10741-017-9619-2 Rangaswami, 2019, Cardiovascular disease in the kidney transplant recipient: epidemiology, diagnosis and management strategies, Nephrol Dial Transplant, 34, 760, 10.1093/ndt/gfz053 Mullens, 2008, Elevated intra-abdominal pressure in acute decompensated heart failure, J Am Coll Cardiol, 51, 300, 10.1016/j.jacc.2007.09.043 Mullens, 2009, Importance of venous congestion for worsening of renal function in advanced decompensated heart failure, J Am Coll Cardiol, 53, 589, 10.1016/j.jacc.2008.05.068 Costanzo, 2017, Extracorporeal ultrafiltration for fluid overload in heart failure: current status and prospects for further research, J Am Coll Cardiol, 69, 2428, 10.1016/j.jacc.2017.03.528 Brisco, 2016, Relevance of changes in serum creatinine during a heart failure trial of decongestive strategies: insights from the DOSE trial, J Card Fail, 22, 753, 10.1016/j.cardfail.2016.06.423 Arrigo, 2018, Cardiorenal interactions revisited: how to improve heart failure outcomes in patients with chronic kidney disease, Circ Heart Fail Rep, 15, 307, 10.1007/s11897-018-0406-8 Costanzo, 2007, Ultrafiltration versus intravenous diuretics for patients hospitalized for acute decompensated heart failure, J Am Coll Cardiol, 49, 675, 10.1016/j.jacc.2006.07.073 Costanzo, 2016, Aquapheresis versus intravenous diuretics and hospitalizations for heart failure, JACC Heart Fail, 4, 95, 10.1016/j.jchf.2015.08.005 Marenzi, 2014, Continuous ultrafiltration for congestive heart failure: the CUORE trial, J Card Fail, 20, 9, 10.1016/j.cardfail.2013.11.004 Grodin, 2018, Comparison of ultrafiltration to pharmacological decongestion in heart failure: a per-protocol analysis of CARRESS-HF, Eur J Heart Fail, 20, 1148, 10.1002/ejhf.1158 Lu, 2015, Peritoneal dialysis in patients with refractory congestive heart failure: a systematic review, Cardiorenal Med, 5, 145, 10.1159/000380915 Zuidema, 2012, Myocardial stunning with hemodialysis: clinical challenges of the cardiorenal patient, Cardiorenal Med, 2, 125, 10.1159/000337476 Braunwald, 1982, The stunned myocardium: prolonged, postischemic ventricular dysfunction, Circulation, 66, 1146, 10.1161/01.CIR.66.6.1146 Burton, 2009, Hemodialysis-induced repetitive myocardial injury results in global and segmental reduction in systolic cardiac function, Clin J Am Soc Nephrol, 4, 1925, 10.2215/CJN.04470709 Flythe, 2015, Association of mortality risk with various definitions of intradialytic hypotension, J Am Soc Nephrol, 26, 724, 10.1681/ASN.2014020222 Stefánsson, 2014, Intradialytic hypotension and risk of cardiovascular disease, Clin J Am Soc Nephrol, 9, 2124, 10.2215/CJN.02680314 Alkhouli, 2015, Cardiac complications of arteriovenous fistulas in patients with end-stage renal disease, Nefrología, 35, 234, 10.1016/j.nefro.2015.03.001 Unal, 2010, The long-term effects of arteriovenous fistula creation on the development of pulmonary hypertension in hemodialysis patients, Hemodial Int, 14, 398, 10.1111/j.1542-4758.2010.00478.x Paneni, 2010, Right ventricular dysfunction in patients with end-stage renal disease, Am J Nephrol, 32, 432, 10.1159/000320755 Wasse, 2012, High-output heart failure: how to define it, when to treat it, and how to treat it, Semin Nephrol, 32, 551, 10.1016/j.semnephrol.2012.10.006 Tsujimura, 2017, Supplementary administration of everolimus reduces cardiac systolic function in kidney transplant recipients, Ann Transplant, 22, 315, 10.12659/AOT.903414 Ronco, 2017, A call to action to develop integrated curricula in cardiorenal medicine, Rev Cardiovasc Med, 18, 93, 10.3909/ricm0891 Kazory, 2018, Cardionephrology: proposal for a futuristic educational approach to a contemporary need, Cardiorenal Med, 8, 296, 10.1159/000490744 House, 2018, Management of heart failure in advancing CKD: core curriculum 2018, Am J Kidney Dis, 72, 284, 10.1053/j.ajkd.2017.12.006 Chiu, 2015, Cardiac imaging in patients with chronic kidney disease, Nat Rev Nephrol, 11, 207, 10.1038/nrneph.2014.243 Marín, 2006, Guidelines of the Spanish Society of Nephrology: the kidney and cardiovascular disease. Short version, Nefrología, 26, 31 Anguita Sánchez, 2016, Classification and quality standards of heart failure units: Scientific consensus of the Spanish Society of Cardiology, Rev Esp Cardiol, 69, 940, 10.1016/j.recesp.2016.06.010 Rangaswami, 2019, Cardiorenal syndrome: classification, pathophysiology, diagnosis, and treatment strategies: a scientific statement from the American Heart Association, Circulation, 139, e840, 10.1161/CIR.0000000000000664 Lin, 2017, Effects of self-management on chronic kidney disease: a meta-analysis, Int J Nurs Stud, 74, 128, 10.1016/j.ijnurstu.2017.06.008 Donald, 2018, Self-management interventions for adults with chronic kidney disease: a scoping review, BMJ Open, 8, e019814, 10.1136/bmjopen-2017-019814 Peng, 2019, Self-management interventions for chronic kidney disease: a systematic review and meta-analysis, BMC Nephrol, 20, 142, 10.1186/s12882-019-1309-y Lainscak, 2011, Self-care management of heart failure: practical recommendations from the Patient Care Committee of the Heart Failure Association of the European Society of Cardiology, Eur J Heart Fail, 13, 115, 10.1093/eurjhf/hfq219 Jenkins, 2010, Heart failure and chronic kidney disease: an integrated care approach, J Ren Care, 36, 127, 10.1111/j.1755-6686.2010.00158.x Mechler, 2019, Palliative care approach to chronic diseases: end stages of heart failure, chronic obstructive pulmonary disease, liver failure, and renal failure, Prim Care, 46, 415, 10.1016/j.pop.2019.05.008 Crews, 2014, Predialysis health, dialysis timing, and outcomes among older United States adults, J Am Soc Nephrol, 25, 370, 10.1681/ASN.2013050567 Leurs, 2015, Timing of dialysis initiation: when to start? Which treatment?, J Ren Nutr, 25, 238, 10.1053/j.jrn.2014.10.015 McCullough, 2016, Intensive hemodialysis, left ventricular hypertrophy, and cardiovascular disease, Am J Kidney Dis, 68, S5, 10.1053/j.ajkd.2016.05.025 Morfin, 2016, Intensive hemodialysis and treatment complications and tolerability, Am J Kidney Dis, 68, S43, 10.1053/j.ajkd.2016.05.021 Odudu, 2015, Randomized controlled trial of individualized dialysate cooling for cardiac protection in hemodialysis patients, Clin J Am Soc Nephrol, 10, 1408, 10.2215/CJN.00200115 Steinwandel, 2018, Can a renal nurse assess fluid status using ultrasound on the inferior vena cava? A cross-sectional interrater study, Hemodial Int, 22, 261, 10.1111/hdi.12606 Steinwandel, 2019, Does the intravascular volume status in haemodialysis patients measured by inferior vena cava ultrasound correlate with bioimpedance spectroscopy?, J Clin Nurs, 28, 2135, 10.1111/jocn.14804 Stoumpos, 2019, Should we ligate arteriovenous fistulas in asymptomatic patients after kidney transplantation?, Circulation, 139, 2819, 10.1161/CIRCULATIONAHA.119.040361 Ibeas, 2017, Spanish clinical guidelines on vascular access for haemodialysis, Nefrología, 37, 1, 10.1016/j.nefro.2017.11.004 Rangaswami, 2018, Resuscitation for the specialty of nephrology: is cardionephrology the answer?, Kidney Int, 93, 25, 10.1016/j.kint.2017.10.002